drugset / Trial / NCT02566655
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
Phase 1
Completed
10 enrolled
Red de Terapia Celular
BIONAND, Universidad de Málaga, IBIMA, Ciber-bbn · collabFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · collabGrupo de Tecnología Sanitaria CIBER-BBN, Inst. Biomecánica de Valencia · collabHospital Universitario Virgen de la Arrixaca · collabInstituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca · collabPublic Health Service, Murcia · collabSpanish National Health System · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of intravenous infusion of fucosylated autologous bone marrow cells as a new therapy in patients with established osteoporosis by a prospective, single-center, open, non-randomized and unblinded clinical trial.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-12
- Completion
- 2018-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fucosylated mesenchymal stem cells | Cell therapy | 2e+06 cells/kg | Intravenous |
| Subject | fucosylated mesenchymal stem cells | Cell therapy | 5e+06 cells/kg | Intravenous |